{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T16:25:00.046590+00:00","company":{"ticker":"CNBX","cik":1343009,"company_name":"CNBX Pharmaceuticals Inc."},"pagination":{"limit":100,"returned":1,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"9106156b4fc3004bad86f96bb888676c9c54a2ed","cik":1343009,"ticker":"CNBX","company_name":"CNBX Pharmaceuticals Inc.","filed_at":"2026-03-17T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Promissory Note","agreement_type":"notes_offering","counterparty":"3i L.P.","effective_date":"2026-03-10","item_codes_triggered":["1.01"],"value_text":"$45,000"},"claim":"CNBX Pharmaceuticals Inc. entered into Promissory Note with 3i L.P. valued at $45,000 (effective 2026-03-10).","evidence_excerpt":"On March 10 th , 2026, the Company executed a non-convertible Promissory Note with 3i L.P., a Delaware Limited Partnership for the amount of $45,000.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001683168-26-001883","anchor_url":"https://secwatch.observer/filing/0001683168-26-001883#claim-9106156b4fc3004bad86f96bb888676c9c54a2ed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1343009/000168316826001883/0001683168-26-001883-index.htm"}]}